Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates With Antitumor Responses

Cancer Research - United States
doi 10.1158/0008-5472.can-06-2925
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of Experimental Asthma by Indoleamine 2,3-Dioxygenase

Journal of Clinical Investigation
Medicine
2004English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Indoleamine 2,3-Dioxygenase Is a Signaling Protein in Long-Term Tolerance by Dendritic Cells

Nature Immunology
AllergyImmunology
2011English

Transient Upregulation of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Human Chorionic Gonadotropin Downregulates Autoimmune Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2007English

Lignans From Carthamus Tinctorius Suppress Tryptophan Breakdown via Indoleamine 2,3-Dioxygenase

Phytomedicine
Molecular MedicinePharmacologyComplementaryAlternative MedicinePharmaceutical ScienceDrug Discovery
2013English

The Modulation of Enzyme Indoleamine 2,3-Dioxygenase From Dendritic Cells for the Treatment of Type 1 Diabetes Mellitus

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Advances in Indoleamine 2,3-Dioxygenase 1 Medicinal Chemistry

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2017English

The Silencing of Indoleamine 2,3-Dioxygenase 1 (IDO1) in Dendritic Cells by siRNA-loaded Lipid Nanoparticles Enhances Cell-Based Cancer Immunotherapy

Scientific Reports
Multidisciplinary
2019English

Induction of Pulmonary Indoleamine 2,3-Dioxygenase by Interferon.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy